| Literature DB >> 32586378 |
Karina Villanueva-Segura1, Gustavo Ponce-Garcia1, Beatriz Lopez-Monroy1, Esteban Mora-Jasso1, Lucia Perales1, Francisco J Gonzalez-Santillan1, Kevin Ontiveros-Zapata1, Jesus A Davila-Barboza1, Adriana E Flores2.
Abstract
BACKGROUND: Knockdown resistance (kdr) is the main mechanism that confers resistance to pyrethroids and DDT. This is a product of non-synonymous mutations in the voltage-gated sodium channel (vgsc) gene, and these mutations produce a change of a single amino acid which reduces the affinity of the target site for the insecticide molecule. In Mexico, V410L, V1016I and F1534C mutations are common in pyrethroid-resistant Aedes aegypti (L.) populations.Entities:
Keywords: Aedes aegypti; F1534C; Multiplex PCR; V1016I; V410L; kdr
Mesh:
Substances:
Year: 2020 PMID: 32586378 PMCID: PMC7318494 DOI: 10.1186/s13071-020-04193-0
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Agarose gel (2.5%) electrophoresis of amplified gDNA products in several mosquitoes using multiplex PCR. The arrows indicate a common band of 368 bp, a band of 232 bp corresponding to the susceptible allele F1534, a band of 180 bp corresponding to the resistant allele C1534, a band of 133 bp corresponding to the susceptible allele V410, a band of 113 bp corresponding to the resistant allele L410, a band of 102 bp corresponding to the susceptible allele V1016, and a band of 82 bp corresponding to the resistant allele I1016. Lane 1: molecular weight marker (25 bp DNA Ladder); Lane 2: a resistant homozygous (C1534/C1534), heterozygous (V410/L410) and heterozygous (V1016/I1016) individual; Lane 3: a resistant homozygous individual (C1534/C1534), resistant homozygous (L410/L410) and resistant homozygous (I1016/I1016); Lane 4: a resistant homozygous individual (C1534/C1534), heterozygous (V410/L410) and resistant homozygous (I1016/I1016); Lane 5: a resistant homozygous individual (C1534/C1534), susceptible homozygous (V410/V410) and heterozygous (V1016/I1016); Lane 6: a resistant homozygous individual (C1534/C1534), heterozygous (V410/L410) and heterozygous (V1016/I1016); Lane 7: a triple susceptible homozygous individual (V410/V410, V1016/V1016 and F1534/F1534)
Comparison of genotyping results for V410L, V1016I, F1534C mutations from multiplex PCR, AS-PCR and DNA sequencing
| Population | Multiplex PCR / AS-PCR/ DNA sequencing | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LL/II/CC | LL/VI/CC | LL/VV/CC | LL/VI/FC | VL/II/CC | VL/VI/CC | VV/II/CC | VV/VI/CC | VL/VI/FC | LL/VV/FF | VV/VI/FC | VV/VV/CC | VL/VV/CC | VL/VV/FC | LL/II/FC | ||
| Monterrey | 1/1/1 | 6/6/6 | 4/4/4 | 0/0/0 | 2/2/2 | 9/9/9 | 1/1/1 | 1/1/1 | 0/0/0 | 0/0/0 | 0/0/0 | 4/4/4 | 0/0/0 | 0/0/0 | 0/0/0 | 28 |
| Guadalupe | 5/5/5 | 6/6/6 | 0/0/0 | 1/1/1 | 4/4/4 | 10/10/10 | 1/1/1 | 3/3/3 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 30 |
| Poza Rica | 0/0/0 | 2/2/2 | 17/17/17 | 0/0/0 | 0/0/0 | 5/5/5 | 2/2/2 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 1/1/1 | 2/2/2 | 0/0/0 | 0/0/0 | 29 |
| Minatitlan | 17/17/17 | 0/0/0 | 0/0/0 | 1/1/1 | 0/0/0 | 1/1/1 | 0/0/0 | 0/0/0 | 0/0/0 | 1/1/1 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 10/10/10 | 30 |
| Cardel | 26/26/26 | 1/1/1 | 0/0/0 | 0/0/0 | 1/1/1 | 2/2/2 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 30 |
| Cosoleacaque | 4/4/4 | 0/0/0 | 0/0/0 | 0/0/0 | 2/2/2 | 10/10/10 | 0/0/0 | 0/0/0 | 1/1/1 | 0/0/0 | 9/9/9 | 0/0/0 | 0/0/0 | 1/1/1 | 0/0/0 | 27 |
| Villa Hermosa | 15/15/15 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 14/14/14 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 1/1/1 | 0/0/0 | 0/0/0 | 0/0/0 | 30 |
| Chiapas | 1/1/1 | 4/4/4 | 0/0/0 | 1/1/1 | 2/2/2 | 14/14/14 | 0/0/0 | 1/1/1 | 4/4/4 | 0/0/0 | 1/1/1 | 0/0/0 | 1/1/1 | 0/0/0 | 0/0/0 | 29 |
| Merida | 9/9/9 | 0/0/0 | 0/0/0 | 0/0/0 | 1/1/1 | 16/16/16 | 0/0/0 | 1/1/1 | 0/0/0 | 0/0/0 | 0/0/0 | 2/2/2 | 1/1/1 | 0/0/0 | 0/0/0 | 30 |
| San Antonio Kaua | 15/15/15 | 0/0/0 | 0/0/0 | 0/0/0 | 1/1/1 | 9/9/9 | 0/0/0 | 3/3/3 | 0/0/0 | 0/0/0 | 0/0/0 | 2/2/2 | 0/0/0 | 0/0/0 | 0/0/0 | 30 |
| Vergel | 9/9/9 | 1/1/1 | 0/0/0 | 0/0/0 | 0/0/0 | 19/19/19 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 0/0/0 | 1/1/1 | 0/0/0 | 0/0/0 | 0/0/0 | 30 |
| Cancun | 3/3/3 | 0/0/0 | 0/0/0 | 0/0/0 | 7/7/7 | 6/6/6 | 6/6/6 | 5/5/5 | 0/0/0 | 0/0/0 | 1/1/1 | 0/0/0 | 0/0/0 | 0/0/0 | 1/1/1 | 29 |
Abbreviations: VV, wild type (susceptible); VL, heterozygotes; LL, mutant (resistant); VI, heterozygotes; II, mutant (resistant); FF, wild type (susceptible); FC, heterozygotes; CC, mutant (resistant); n sample size
Comparison of genotypes for V410L, V1016I and F1534C mutations for multiplex PCR, AS-PCR and DNA sequencing
| Population | Multiplex PCR / AS-PCR/ DNA sequencing | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 410 | Frequency | 1016 | Frequency | 1534 | Frequency | ||||||||
| VV | VL | LL | L410 | VV | VI | II | I1016 | FF | FC | CC | C1534 | ||
| Monterrey | 28 | 6/6/6 | 11/11/11 | 11/11/11 | 0.59 | 8/8/8 | 16/16/16 | 4/4/4 | 0.43 | 0/0/0 | 0/0/0 | 28/28/28 | 1.0 |
| Guadalupe | 30 | 4/4/4 | 14/14/14 | 12/12/12 | 0.63 | 0/0/0 | 20/20/20 | 10/10/10 | 0.67 | 0/0/0 | 1/1/1 | 29/29/29 | 0.98 |
| Poza Rica | 29 | 3/3/3 | 7/7/7 | 19/19/19 | 0.78 | 20/20/20 | 7/7/7 | 2/2/2 | 0.19 | 0/0/0 | 0/0/0 | 29/29/29 | 1.0 |
| Minatitlan | 30 | 0/0/0 | 1/1/1 | 29/29/29 | 0.98 | 1/1/1 | 2/2/2 | 27/27/27 | 0.97 | 1/1/1 | 11/11/11 | 18/18/18 | 0.78 |
| Cardel | 30 | 0/0/0 | 3/3/3 | 27/27/27 | 0.95 | 0/0/0 | 3/3/3 | 27/27/27 | 0.95 | 0/0/0 | 0/0/0 | 30/30/30 | 1.0 |
| Cosoleacaque | 27 | 10/10/10 | 13/13/13 | 4/4/4 | 0.39 | 1/1/1 | 20/20/20 | 6/6/6 | 0.59 | 0/0/0 | 10/10/10 | 17/17/17 | 0.81 |
| Villa Hermosa | 30 | 1/1/1 | 14/14/14 | 15/15/15 | 0.73 | 1/1/1 | 15/15/15 | 14/14/14 | 0.72 | 0/0/0 | 0/0/0 | 30/30/30 | 1.0 |
| Chiapas | 29 | 2/2/2 | 21/21/21 | 6/6/6 | 0.57 | 1/1/1 | 25/25/25 | 3/3/3 | 0.53 | 0/0/0 | 6/6/6 | 23/23/23 | 0.90 |
| Merida | 30 | 3/3/3 | 18/18/18 | 9/9/9 | 0.60 | 3/3/3 | 17/17/17 | 10/10/10 | 0.62 | 0/0/0 | 0/0/0 | 30/30/30 | 1.0 |
| San Antonio Kaua | 30 | 5/5/5 | 10/10/10 | 15/15/15 | 0.67 | 2/2/2 | 12/12/12 | 16/16/16 | 0.73 | 0/0/0 | 0/0/0 | 30/30/30 | 1.0 |
| Vergel | 30 | 1/1/1 | 19/19/19 | 10/10/10 | 0.65 | 1/1/1 | 20/20/20 | 9/9/9 | 0.63 | 0/0/0 | 0/0/0 | 30/30/30 | 1.0 |
| Cancun | 29 | 12/12/12 | 13/13/13 | 4/4/4 | 0.36 | 0/0/0 | 12/12/12 | 17/17/17 | 0.79 | 0/0/0 | 2/2/2 | 27/27/27 | 0.97 |
Abbreviations: VV, wild type (susceptible); VL, heterozygotes; LL, mutant (resistant); VI, heterozygotes; II, mutant (resistant); FF, wild type (susceptible); FC, heterozygotes; CC, mutant (resistant); n sample size